Your browser doesn't support javascript.
loading
Associations amongst genes, molecules, cells, and organs in breast cancer metastasis.
Nathanson, S David; Dieterich, Lothar C; Zhang, Xiang H-F; Chitale, Dhananjay A; Pusztai, Lajos; Reynaud, Emma; Wu, Yi-Hsuan; Ríos-Hoyo, Alejandro.
Afiliación
  • Nathanson SD; Department of Surgery, Henry Ford Health, 2799 W. Grand Blvd, Detroit, MI, 48202, USA. dnathan1@hfhs.org.
  • Dieterich LC; Cancer Center, Henry Ford Health, Detroit, MI, USA. dnathan1@hfhs.org.
  • Zhang XH; European Center for Angioscience (ECAS), Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
  • Chitale DA; Lester and Sue Smith Breast Center, Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Pusztai L; Department of Pathology, Henry Ford Health, Detroit, MI, USA.
  • Reynaud E; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
  • Wu YH; European Center for Angioscience (ECAS), Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
  • Ríos-Hoyo A; Lester and Sue Smith Breast Center, Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Clin Exp Metastasis ; 2023 Sep 09.
Article en En | MEDLINE | ID: mdl-37688650
ABSTRACT
This paper is a cross fertilization of ideas about the importance of molecular aspects of breast cancer metastasis by basic scientists, a pathologist, and clinical oncologists at the Henry Ford Health symposium. We address four major topics (i) the complex roles of lymphatic endothelial cells and the molecules that stimulate them to enhance lymph node and systemic metastasis and influence the anti-tumor immunity that might inhibit metastasis; (ii) the interaction of molecules and cells when breast cancer spreads to bone, and how bone metastases may themselves spread to internal viscera; (iii) how molecular expression and morphologic subtypes of breast cancer assist clinicians in determining which patients to treat with more or less aggressive therapies; (iv) how the outcomes of patients with oligometastases in breast cancer are different from those with multiple metastases and how that could justify the aggressive treatment of these patients with the hope of cure.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Exp Metastasis Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Exp Metastasis Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos